Published in CNS Neurol Disord Drug Targets on January 01, 2016
Chapter 3: Histology of the peripheral nerve and changes occurring during nerve regeneration. Int Rev Neurobiol (2009) 1.57
Chronic ketamine use increases serum levels of brain-derived neurotrophic factor. Psychopharmacology (Berl) (2010) 1.57
Neurologic soft signs in schizophrenic patients treated with conventional and atypical antipsychotics. J Clin Psychopharmacol (2005) 1.49
Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatment. Schizophr Res (2009) 1.48
Structural alterations in subcutaneous small resistance arteries predict changes in the renal function of hypertensive patients. J Hypertens (2010) 1.46
Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial. Addiction (2010) 1.44
Behavioural addictions in adolescents and young adults: results from a prevalence study. J Gambl Stud (2011) 1.37
SDF and GABA interact to regulate axophilic migration of GnRH neurons. J Cell Sci (2012) 1.24
Is theory of mind in schizophrenia more strongly associated with clinical and social functioning than with neurocognitive deficits? Psychopathology (2002) 1.23
Prefrontal-thalamic-cerebellar gray matter networks and executive functioning in schizophrenia. Schizophr Res (2007) 1.17
Anhedonia and substance dependence: clinical correlates and treatment options. Front Psychiatry (2011) 1.17
Novel psychoactive substances of interest for psychiatry. World Psychiatry (2015) 1.17
The Homer family and the signal transduction system at glutamatergic postsynaptic density: potential role in behavior and pharmacotherapy. Psychopharmacol Bull (2003) 1.10
Chapter 5: Methods and protocols in peripheral nerve regeneration experimental research: part II-morphological techniques. Int Rev Neurobiol (2009) 1.09
Dead under the bed: a case of Diogenes syndrome? Int J Geriatr Psychiatry (2013) 1.07
Effects of 50 Hz electromagnetic fields on voltage-gated Ca2+ channels and their role in modulation of neuroendocrine cell proliferation and death. Cell Calcium (2004) 1.04
Agomelatine versus venlafaxine XR in the treatment of anhedonia in major depressive disorder: a pilot study. J Clin Psychopharmacol (2012) 1.04
Reduced fronto-temporal connectivity is associated with frontal gray matter density reduction and neuropsychological deficit in schizophrenia. Schizophr Res (2008) 1.03
Efficacy and safety of aripiprazole in alcohol dependence. Am J Drug Alcohol Abuse (2007) 1.02
Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis. Int J Neuropsychopharmacol (2007) 1.02
Dysregulation of chemo-cytokine production in schizophrenic patients versus healthy controls. BMC Neurosci (2011) 1.01
Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice. J Clin Invest (2013) 0.99
Behavioural addictions in bipolar disorder patients: role of impulsivity and personality dimensions. J Affect Disord (2010) 0.98
Alexithymia and its relationships with dissociative experiences and Internet addiction in a nonclinical sample. Cyberpsychol Behav (2009) 0.98
Targeting glutamate system for novel antipsychotic approaches: relevance for residual psychotic symptoms and treatment resistant schizophrenia. Eur J Pharmacol (2012) 0.98
Pregabalin in clinical psychiatry and addiction: pros and cons. Expert Opin Investig Drugs (2012) 0.97
The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia. World Psychiatry (2014) 0.96
Importance of cyberspace for the assessment of the drug abuse market: preliminary results from the Psychonaut 2002 project. Cyberpsychol Behav (2003) 0.95
Substance abuse and suicide risk among adolescents. Eur Arch Psychiatry Clin Neurosci (2012) 0.95
Bipolar disorder and epilepsy: a bidirectional relation? Neurobiological underpinnings, current hypotheses, and future research directions. Neuroscientist (2007) 0.95
Clonazepam in the treatment of psychiatric disorders: an update. Int Clin Psychopharmacol (2006) 0.95
Approximate entropy of respiratory patterns in panic disorder. Am J Psychiatry (2004) 0.94
Treatment of antipsychotic-induced hyperprolactinemia: an update on the role of the dopaminergic receptors D2 partial agonist aripiprazole. Recent Pat Endocr Metab Immune Drug Discov (2014) 0.94
Alexithymia and its relationships with body checking and body image in a non-clinical female sample. Eat Behav (2006) 0.93
New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 ('Blue Mystic'). J Psychopharmacol (2005) 0.93
Permanent focal brain ischemia induces isoform-dependent changes in the pattern of Na+/Ca2+ exchanger gene expression in the ischemic core, periinfarct area, and intact brain regions. J Cereb Blood Flow Metab (2006) 0.92
Can regenerated nerve fibers return to normal size? A long-term post-traumatic study of the rat median nerve crush injury model. Microsurgery (2012) 0.92
The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice. Int J Mol Sci (2013) 0.92
Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up. J Affect Disord (2008) 0.91
Activin A induces Langerhans cell differentiation in vitro and in human skin explants. PLoS One (2008) 0.91
"Spice," "kryptonite," "black mamba": an overview of brand names and marketing strategies of novel psychoactive substances on the web. J Psychoactive Drugs (2014) 0.91
A case of Cotard's Syndrome successfully treated with aripiprazole monotherapy. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.90
A possible new option for migraine management: agomelatine. Clin Neuropharmacol (2013) 0.90
Perspectives in regeneration and tissue engineering of peripheral nerves. Ann Anat (2011) 0.90
Panic disorder respiratory subtype: psychopathology, laboratory challenge tests, and response to treatment. Harv Rev Psychiatry (2010) 0.89
Anhedonia and major depression: the role of agomelatine. Eur Neuropsychopharmacol (2012) 0.89
Targeting the Noradrenergic System in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis of Prazosin Trials. Curr Drug Targets (2015) 0.89
Inferior frontal white matter volume and suicidality in schizophrenia. Psychiatry Res (2008) 0.89
Cannabis use and psychosis: theme introduction. Curr Pharm Des (2012) 0.88
The language of schizophrenia: an analysis of micro and macrolinguistic abilities and their neuropsychological correlates. Schizophr Res (2008) 0.88
Psychometric characteristic of the Italian version of the Temperament and Character Inventory--revised, personality, psychopathology, and attachment styles. Compr Psychiatry (2008) 0.88
Reduced hedonic capacity in euthymic bipolar subjects: a trait-like feature? J Affect Disord (2012) 0.88
The potential of pregabalin in neurology, psychiatry and addiction: a qualitative overview. Curr Pharm Des (2013) 0.88
Decreased levels of D-aspartate and NMDA in the prefrontal cortex and striatum of patients with schizophrenia. J Psychiatr Res (2013) 0.87
Craving Typology Questionnaire (CTQ): a scale for alcohol craving in normal controls and alcoholics. Compr Psychiatry (2013) 0.87
Association of antipsychotic induced weight gain and body mass index with GNB3 gene: a meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.87
Neurosteroid secretion in panic disorder. Psychiatry Res (2003) 0.87
Freezing reaction in panic disorder patients associated with anticipatory anxiety. Depress Anxiety (2009) 0.87
Are atypical depression, borderline personality disorder and bipolar II disorder overlapping manifestations of a common cyclothymic diathesis? World Psychiatry (2011) 0.87
Smoking and respiratory irregularity in panic disorder. Biol Psychiatry (2004) 0.87
Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis. Prog Neuropsychopharmacol Biol Psychiatry (2013) 0.86